Shigeki Aoki

14PUBLICATIONS

48CO-AUTHORS

Molecular targetsMajor global burdens of diseaseEnvironmental epidemiologyPredictive and prognostic markersInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 26, 2026

Dual targeting of glutamine metabolism and lysosomal function in eliminating drug-tolerant KRAS-mutant cancer cells.

|Aug 14, 2024

Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.

Natsumi Hama, Shigeki Aoki, Chun-Bing Chen

|Apr 17, 2024

HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir.

Akira Kazaoka, Sota Fujimori, Yushiro Yamada

|Apr 05, 2024

Potential role of lipophagy impairment for anticancer effects of glycolysis-suppressed pancreatic ductal adenocarcinoma cells.

Zhiheng Zhang, Haruna Aoki, Keitaro Umezawa

|Mar 25, 2024

Pathological changes in various organs in HLA-B*57:01 transgenic mice with abacavir-induced skin eruption.

Akira Kazaoka, Kazuyoshi Kumagai, Junya Matsushita

|Sep 29, 2021

Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.

Takeshi Susukida, Saki Kuwahara, Binbin Song

Pageof 3

Frequent Collaborators

M Hori

A Hagiwara

C Andica

K Yokoyama

K K Kumamaru

M Nakazawa

N Takano

R Irie

K Kamagata

N Hamasaki

Frequent Collaborators

M Hori

A Hagiwara

C Andica

K Yokoyama